Abstract:Depression is associated with a lowered degree of esterification of serum cholesterol, an increased C20:4ω6/C20:5ω3 ratio and decreases in ω3 fractions in fatty acids (FAs) or in the red blood cell membrane. The aims of the present study were to examine: (i) serum phospholipid and cholesteryl ester compositions of individual saturated fatty acids (SFAs), monounsaturated FAs (MUFAs) and polyunsaturated FAs (PUFAs) in major depressed patients vs. healthy volunteers; (ii) the relationships between the above FAs and lowered serum zinc (Zn), a marker of the inflammatory response in depression; and (iii) the effects of subchronic treatment with antidepressants on FAs in depression. The composition of the FAs was determined by means of thin layer chromatography in conjunction with gas chromatography. Lipid concentrations were assayed by enzymatic colorimetric methods. The oxidative potential index (OPI) of FAs was computed in 34 major depressed inpatients and 14 normal volunteers. Major depression was associated with: increased MUFA and C22:5ω3 proportions and increased C20:4ω6/C20:5ω3 and C22:5ω6/C22:6ω3 ratios; lower C22:4ω6, C20:5ω3 and C22:5ω3 fractions in phospholipids; lower C18:3ω3, C20:5ω3 and total (Σ)ω3 FAs, and higher C20:4ω6/C20:5ω3 and Σω6/Σω3 ratios in cholesteryl esters; lower serum concentrations of phospholipids and cholesteryl esters; and a decreased OPI. In depression, there were significant and positive correlations between serum Zn and C20:5ω3 and C22:6ω3 fractions in phospholipids; and significant inverse correlations between serum Zn and the Σω6/Σω3, C20:4ω6/C20:5ω3, and C22:5ω6/C22:6ω3 ratios in phospholipids. There was no significant effect of antidepressive treatment on any of the FAs. The results show that, in major depression, there is a deficiency of ω3 PUFAs and a compensatory increase in MUFAs and C22:5ω6 in phospholipids. The results suggest that: (i) there is an abnormal metabolism of ω3 PUFAs in depression; (ii) the FA alterations in depression are related to the inflammatory response in that illness; and (iii) the disorders may persist despite successful antidepressant treatment.

In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.

Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.

Decreased Dehydroepiandrosterone Sulfate but Normal Insulin-Like Growth Factor in Chronic Fatigue Syndrome (cfs): Relevance for the Inflammatory Response in Cfs

Lowered Ω3 Polyunsaturated Fatty Acids in Serum Phospholipids and Cholesteryl Esters of Depressed Patients

Chronic Fatigue Syndrome is Accompanied by an Igm-Related Immune Response Directed Against Neopitopes Formed by Oxidative or Nitrosative Damage to Lipids and Proteins

Environmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome

Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs), Somatic and Fatigue Symptoms in Cardiovascular Diseases Comorbid Major Depressive Disorder (MDD): A Randomised Controlled Trial

Not in the Mind but in the Cell: Increased Production of Cyclo-Oxygenase-2 and Inducible NO Synthase in Chronic Fatigue Syndrome.

Fatty Acid Composition in Major Depression: Decreased Ω3 Fractions in Cholesteryl Esters and Increased C20:4ω6C20:5ω3 Ratio in Cholesteryl Esters and Phospholipids

An IgM-mediated Immune Response Directed Against Nitro-Bovine Serum Albumin (Nitro-Bsa) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That Nitrosative Stress is Another Factor Underpinning the Comorbidity Between Major Depression and CFS.

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways

Increased Serum IgM Antibodies Directed Against Phosphatidyl Inositol (pi) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That an IgM-mediated Immune Response Against Pi is One Factor Underpinning the Comorbidity Between Both CFS and Depression.

Increased Plasma Peroxides As A Marker of Oxidative Stress in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Me/cfs)

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression

Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery

In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms Are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity

Coenzyme Q10 Deficiency in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (me/cfs) is Related to Fatigue, Autonomic and Neurocognitive Symptoms and is Another Risk Factor Explaining the Early Mortality in Me/Cfs Due to Cardiovascular Disorder

Serum Agrin and Talin Are Increased in Major Depression While Agrin and Creatine Phosphokinase Are Associated with Chronic Fatigue and Fibromyalgia Symptoms in Depression.

Not in the Mind of Neurasthenic Lazybones but in the Cell Nucleus: Patients with Chronic Fatigue Syndrome Have Increased Production of Nuclear Factor Kappa Beta

Aberrations in the Cross-Talks among Redox, Nuclear Factor-κB and Wnt/Catenin Pathway Signaling Underpin Myalgic Encephalomyelitis Andchronic Fatigue Syndrome: A Review and New Hypothesis Based on Results of Network, Enrichment and Annotation Analyses

Leaky Gut In Chronic Fatigue Syndrome: A Review